The main objective of this study was to evaluate the biological activity of a new compound (derived from aza-bicyclo-carboxylic acid) against heart failure caused by the ischemiareperfusion phenomenon. In addition, to characterize de molecular mechanism involved in the effect exerted by aza-bicyclo-carboxylic acid against infarction area, somedrugssuch as prazosin, metoprolol, propanolol, tamoxifen, flutamide, finasteride, nifedipine,levosimedan, adenosine, rolofylline, isoproterenol and the compound ZM-241385were used as pharmacological tools. The data found indicated that biological activity induced by compound 3on infarction area only was similar at effect exerted by adenosine; however, the effect produced by compound 3 was blocked with of rolofylline.Other data showed that the biological activity of compound 3 decreases the cAMP levels in a time-dependent manner.In conclusion, the results indicate that compound 3 can produce a cardioprotective effect against myocardial ischemia-reperfusion injury translated as a decrease on infarction area; this phenomenon involves A 1 -adenosine receptor activation and, as a result may cause changes in cAMP levels.
Heart failure is the main cause of death in patients with heart disease [1] [2] [3] ; this phenomenon is due to the cardiac myocyte cell death caused by prolonged myocardial ischemia that can be translated as myocardial infarction,which consequently results in some changes in the cardiac work of both ventricles 4, 5 . Several reports suggest that restoration of blood flow in some case can decrease the cardiac necrosis; nevertheless, other studies indicate that the reperfusion may increase the tissue injury 6 . It is important to mention, that there are several drugs such as the Cyclosporin-Awhich showed biological activity against ischemia-reperfusion injury in an animal model 7 . Other data indicate that rapamycin which can exert benefic effectson myocardial infarction in isolated mouse heart via mitochondrial potassium channel activation 8 .In addition, a study showed that glibenclamide reduces myocardial damage in ischemia-reperfusionmodel through potassium channel activation 9 .Also, a study showed that a benzenamine-derivative (SEA0400) can decrease the reperfusion injury using some "in vitro" and "in vivo" models 10 .Recently, a study showed that a naphthalene-prazosin derivative exerts a cardioprotective effect against myocardial necrosis after ischemia-reperfusion injury via the calcium channels activation 11 .All these results indicate that some compounds may exert effects on reperfusioninjury; however, the cell site where they produce their biological activity is not very clear. To characterize this phenomenon, the biological activity exerted by an aza-bicyclo-carboxylic acid derivative was evaluated using an ischemiareperfusion injury model.
Material and Methods

General methods
The compounds 3-(2-Amino-ethyl)-1,5-dinitro-9-(3-oxo-butyl)-3-aza-bicyclo[3.3.1] non-6-ene-7-carboxylic acid (1)and (2-Acetyl9a-methyl-7-oxo-dodecahydro-cyclopenta [a] naphthalen-8-yl)-acetic acid (2) were prepared using a previously methods reported 12, 13 . All chemicals were analytical grade supplied by Sigma-Aldrich Co. Ltd. Elemental analysis was performed with an elemental analyzer (Perkin Elmer Ser. II CHNS/0 2400). Infrared spectra were recorded with a FTR iS50 apparatus. Mass spectra were recorded with a Finnigan Trace GCPolaris Q. NMR spectra were obtained using a Varian VXR-300/5 FT NMR spectrometer at 300 and 75.4 MHz in CDCl 3 .
Chemical synthesis
Synthesis
In a round bottom flask (10 ml), the compound 1(200 mg, 0.55 mmol), compound 2(60 µl, 0.90 mmol), boric acid (50 mg, 0.80 mmol) and 5 ml of methanol were placed. After, the mixturewas stirred for 72 h to room temperature. The reaction product was dried under reduced pressure and purified by crystallization using the methanol:water (4:1) system.
Biological activity
All It is noteworthy,that drugs involved in this study were dissolved in methanol and from this solution all dilutions were obtained using a Krebs-Henseleit* solution (v/v).
experimental design i
Animals were anesthetized with pentobarbital (50 mg/Kg body weight) via intraperitoneal administration. After the animal was opened by a thoracic abdominal laparotomy and the heart was perfused via retrogradewith the Krebs-Henseleit solution through a non-circulating perfusion system with a constant flow rate.It is important that the study population involved in each group was n = 9.
*Krebs-Henseleit solution (pH = 7.4, 37°C) composed by following system; 117.8 NaCl; 6 KCl; 1.75 CaCl 2 ; 1.2 NaH 2 PO 4 ; 1.2 MgSO 4 ; 24.2 NaHCO 3 ; 5 glucose and 5 sodium pyruvate (mmol). The solution was then bubbled with a mixture of O 2 /CO 2 (95:5/5 %). The coronary flow (10 ml/min) was adjusted with a peristaltic pump and a period of equilibration was carried out for 15 min.
ischemia-reperfusion model
It is important to mention that after the equilibrium time; the hearts underwent a period of ischemia for 40 minutes due to closure of the perfusion system such as indicate some reports 15 in absence (control) or presence of each of drug involved in this study (see design experimental).
Following, the system was restarted and the hearts were reperfused by other 40 minutes with KrebsHenseleit solution.
histological analysis
For histological evaluation, the technique modifies reported by Engelhardt 16 was used. Cross sections from the heart were fixed with 10% paraformaldehyde for 8 h. Then, the samples are placed in a histocasette (Leica Mod. TP1020 SN: 042231418), for 12 h to be processed. After, the sections of heart were placed in a Paraffin Embedding Center (Leica EG1160 model) to form paraffin blocks which are cut into 2 µm slices using an aparatus Leica 50138178 model and following were introduced to bath water (Riossa-Rocha B7 SN: 070909 model). Then, the samples were placed on a slide, which was dried at 60 o C for 30 minutes in a Binder-ED23 apparatus. After, a solution of ethanol:xylol (1: 1) was added to the slides for cell clearance; then of 10 minutes, was washed with distilled water.To observe the tissue morphology, hematoxylin is added to the sample (for 1 minute), after which time it is washed again. Then eosin is added for 1 minute. Finally, ethanol/xylol (1:1) is added to the sample and the tissue is observed under the microscope. For morphometrical analysis, photographs of 20 ventricular sections were taken at 3320 magnifications (ZeissIM-35). Biological evaluation step i effects induced by the compound 1 against infarct area The effect induced by the compound 1on ischemiareperfusion injury (translated as infarction area)was evaluated at dose of 0.001-100 nM.
After of each experiment the hearts were cut into two sections at right angles to the vertical axis. It is important to mention that the areas of the normal left ventricle non-risk region, area at risk, and infarct region were evaluated using a previously reported method 17, 18 . Biological activity produced by the compounds 1, 2 and 3 against infarct area
The effect induced by the compounds 1, 2 and 3 (at a dose of 0.001 nM) on the ischemiareperfusion injury (translated as infarction area) was determined.
step ii
The biological activityinduced by compound 3 on ischemia-reperfusion injury translated as infarction areawas compared with effect exerted by different drugs involved in this study. In addition, it noteworthy that different doses administered in this study of each drug used as pharmacological tools have been previously reported [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] . evaluation of biological activity of the compound 3against infarction area via sex hormons
The effect induced by the compounds 3 (0.001 nMm/min) ortamoxifen(1nMm/min) or finasteride (nMm/min) or flutamide (nMm/min) on the ischemia-reperfusion injury (translated as infarction area) was determined. determination of biological effect of the compound 3 against infarction area through of adrenergic system The effect exerted by the compounds 3 (0.001 nM) orprazosin (nMm/min), or propanolol (nMm/ min) or metoprolol (nMm/min),on the ischemiareperfusion injury (translated as infarction area) was asses.
evaluation of biological activity of the compound 3 against infarction area via calcium channels
The effect induced by the compounds 3 (0.001 nM) or nifedipine (10 nM/min) or levosimedan (0.1 ìM/min) on the ischemiareperfusion injury (translated as infarction area) was determined. determination of biological effect of the compound 3 against infarction area through phosphodiesterase inhibition
The effect exerted by the compounds 3 (0.001 nM) ormilrinone (0.025 µM/min),on the ischemia-reperfusion injury (translated as infarction area) was asses.
evaluation of biological activity of the compound 3 against infarction area via atP-ase inhibition
The effect induced by the compounds 3 (0.001 nM) ordigoxine (20 µM/min) on the ischemia-reperfusion injury (translated as infarction area) was determined. determination of biological effect of the compound 3 against infarction area throughpurinergic system The effect exerted by the compounds 3 (0.001 nM) oradenosine(140µg/min),on the ischemiareperfusion injury (translated as infarction area) was asses.
step iii Biological activity exerted of compound 3 against infarct area via adenosine receptors
The compound 3 was perfused(1 nM/ min) in the hearts and infarct area was evaluated; then this experiment was repeated in presence of rolofylline (1 µM) 28 or ZM-241385(1´ 10 -7 M/ min) 29 .
step iV effect exerted of Compound 3 on caMP concentration
Isoproterenol (100 nM / min) was perfused on the heart for 3, 6, 9, 12 or 18 minutes and its effect on cAMP levels was determined using a previously reported method 39, 31 . After, the results obtained were compared with the biological activity exerted by the compound 3(1 nM/min) and control on the concentration of cAMP.
statistical analysis
The results were expressed as average ± SE, using each heart (n = 9) as its own control. In addition,theresults were analyzed via Analysis of Variance using the SPSS 12.0 program 32 . The differences in the values found were determinateswithp = 0.05.
results
Preparation of compound 3
Aza-bicyclo-carboxylic acid derivative (compound 3) was prepared by the reaction of 1 with 2in presence of boric acid;yielding 75% of product ( Figure 1) The data indicated that compound 3 significantly decreased (p = 0.05) infarct size (percentage of area at risk) in a dose-dependent manner in comparison with thecontrol ( Figure 2 ).
histological issue evaluation
In the Figures 3 and 4are shown a marked disruption of the myocardial structure characterized by appearance of extensive necrosis in conditions control; however this is lower in presence of compound 3. effects exerted by the compound 1-3
The biological activity induced by the compounds 1, 2 and 3 at a dose of 0.001 nM/min on infarct area were evaluated using an ischemia injury model. The experimental data found shown that compound 3 significantly decreases (p = 0.05) the infarct area compared with compounds 1, 2 and control conditions ( Figure 5 ). effects induced bythe compound 3 against ischemia-reperfusion injury via sex hormones
The effect exerted by the compounds 1, 2,3 and control conditions on infarct area were evaluated using an ischemia-reperfusion injury model ( Figure 6 
disCussion
Several drugs have been used for treatment of ischemia-reperfusion such as propofol 33 , methylene blue 34 ,resveratrol 35 ,rapamycin 36 ,nitroderivative 37 and others; however, each drug exerts its biological activity on the ischemia-reperfusion injury, throughofseveral molecular mechanisms; this phenomenon could be the result of its different chemical characteristics. Therefore, in this study was prepared a new drug (aza-bicyclo-carboxylic acid derivative) to evaluate their biological activity againstischemia-reperfusion injury.
Chemical synthesis
There are several methods for preparation of azabicyclic; however, some reagents used require special conditions [38] [39] [40] ;analyzing this data, in this report a new azabicyclic derivative was prepared using different chemical strategies. It is noteworthy, that in this reaction an amino-bicyclo (compound 1) was bound to the carboxyl group (Figure 1 ). Chemical structure of compound 3 was determinate using NMR spectroscopy (Table 1 and Table 2 Fig. 4 . Histological evaluation of effect exerted by compound 3 against ischemia-reperfusion using the technique modifies reported by Engelhardt [28] . In the scheme E (control)a marked alteration of the structure of the myocardium section characterized by the appearance of extensive necrosis, bands of contraction and thinning of myofibrils were observed. In addition, in the scheme Fis shown a decreased of myocardial necrosis by presence of compound 3 ppm for ketone groups. Finally, mass spectrum of compound 3 showed a molecular ion at m/z 658.32.
Biological activity effect induced by the compound 3against ischemia injury
In this study, biological activity induced by the compound 3 to different doses against infarct area were evaluated using an ischemia-reperfusion injury model.The experimental data found shown The experimental data found shown that cAMP levels was lower (p = 0.05) in the presence of the compound 3compared with isoproterenol (3-18 min) and the control. The values indicate the mean ± S.E. of 6 experiments that compound 3 decreased the infarct area in a dose-dependent manner.Analyzing these results, other experiments were also carried out, in which the biological activity of compounds 1 and 2 was evaluated, to rule out the possibility that any of these compounds could exert some effect on the ischemia-reperfusion injury.The resultsshowed that compound 3 significantly decrease the infarct area compared with compounds 1, 2 and control conditions( Figure 2 and 3) ; this phenomenon, indicated that the different functional groups involved in the chemical structure of 3 are the responsible for their biological activity against the ischemia-reperfusion injury translated as a reduction on infarction area. Characterization of molecular mechanism involved in the biological activityinduced by the compound 3 againstischemia-injury Analyzing data above mentioned and other reports which suggest that some drugs can produce effects on ischemia injury via activation of 5-alpha-reductase 41 or interaction withbothandrogens and estrogens receptors 42, 43 ; in this study,the effect exerted by finasteride (5-alphareductase inhibitor) or tamoxifen (estrogen receptor antagonist) or flutamide (androgen receptor inhibitor)against ischemia-reperfusion injury was determinate and compared with the effect exerted by compound 3. The results shown that compound 3 exert different biological activity compared with finasteride or tamoxifen or flutamide ( Figure 4) ; these resultssuggest that molecular mechanism involved in the effect induced by the compound 3 on ischemia-reperfusion injury was not via sex hormones activation.
On the other hand, also, other reports which suggest that ischemia-reperfusion injury may be reduced via adrenergic system activation [44] [45] [46] were analyzed. Therefore, in this experimental study, the pharmacological activity exerted by prazosin or propranolol or metoprolol on ischemia injury was evaluated and compared with effect produce by compound 3 against ischemia-reperfusion injury.The data found shown that infarct area was lower in presence of compound 3 in comparison with prazosin, propanolol or metoprolol; this data suggest that effect exerted by the compound 3 on ischemia-reperfusion injury was not via a 1 or b 1 receptors activation.
Analyzing these data,and other studies which suggest that some drugs can induce effects against ischemia-reperfusion injury viacalcium channel activation 47, 48 ; in this experimental investigation, the pharmacological activity induced by nifedipine (calcium antagonist) or levosimedan(calcium sensitizer) 49 on ischemiareperfusion injury was evaluated and compared with the biological activity induced by compound 3. The experimental results found shown that effect exerted by 3 was lower in comparison with nifedipine and levosimedan; this data indicated that molecular mechanism involved by 3 was not viacalcium channels activation.
On The other hand,in this study was also validated the effect exerted by milrinone (phosphodiesterase inhibitor III) 50 on myocardial infarct size to compare withbiological activity exerted by compound 3.The experimental dataindicated that compound 3decreased infarct area was lower in comparison with biological activity of milrinone; these data indicated that molecular involved in the effect exerted by the compound 3 was not through of inhibition or activation of some phosphodiesterase.
In the search for the possible molecular mechanism involved in the effect exerted by compound 3, other reports were also analyzed; these studies indicate that ischemia-reperfusion in the subepicardial regions of ischemic tissue can be reduced in the presence of digoxin 51 .Therefore,the effect produced by digoxin on ischemia-reperfusion injury was determinedand compared with the effect exerted bythecompound 3. The experimental data found shown that digoxin decreased the infarct area in comparison with control conditions; however, it is noteworthy that this effect was different compared with the compound 3; this results indicated that molecular mechanism was not via Na
Finally, other experiments were carried out to characterize the mechanism by which compound 3 induces its effect againstischemia-reperfusion injury. In this sense, the effect exerted by adenosine on the ischemia-reperfusion injury was evaluated and compared with the biological activity exerted by compound 3.The experimental data showed that the infarct area decreased in a similar way to the biological activity induced by compound 3. These results suggest that molecular mechanism could involve adenosine receptors 52 ; to check this hypothesis; the effect exerted by compound 3against ischemia-reperfusion injury was evaluated in presence of rolofylline(A 1 -adenosine receptor antagonist) 53 orZM-241385 (A 2 -adenosine receptor inhibitor) 54 . The experimental data found shown that biological activity exerted by the compound was only inhibited in presence of rolofylline; thisresults indicated that the molecular mechanism involved in the biological activity exerted by the compound 3 against ischemia-reperfusion injury which is translated as a decrease in the area of infarction was via A 1 -receptor activation; however, it is noteworthy that there are other reports which indicate that A 1 -Adenosine receptoractivationcan induce changes in cAMP levels 55 . Therefore, also the effectexerted by compound3on cAMP concentration was evaluated using isoproterenol as control. The experimental data found shownthat compound 3decreased the cAMP levels (3-18 min) in comparison withisoproterenol and control conditions. Theseresults suggest that effect exerted by the compound 3against ischemia-reperfusion injury translated as decreased of infarct area involves A 1 -adenosine receptor activation and consequently brings changes of cAMP levels.
ConClusions
The results indicate that compound 3 can produce a cardioprotective effect against myocardial ischemia-reperfusion injury translated as a decrease on infarction area; this phenomenon involves A 1 -adenosine receptor activation and, as a result may cause changes in cAMP levels. 
